BioCentury | Apr 1, 2013
Clinical News

Viscogel: Phase I/II data

...about 130 healthy volunteers showed that single ascending-doses of ViscoGel as an adjuvant to the ActHIB...
...as an adjuvant to ActHIB increased antibody responses and significantly increased cellular immune responses vs. ActHIB...
...European companies and academic institutions are part of ViVac. Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) markets ActHIB...
BioCentury | Apr 30, 2012
Clinical News

Viscogel: Phase I/II started

...vaccine vs. 0.2, 2 and 10 µg ActHIB alone. Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) markets ActHIB...
BioCentury | May 2, 2011
Clinical News

V419: Phase III started

...months of age, a modified process hepatitis B vaccine at 2 and 6 months and ActHib...
...Europe, while Merck markets it elsewhere. Merck and Sanofi Pasteur market Hib vaccines PedvaxHib and ActHIB...
BioCentury | Apr 4, 2011
Clinical News

Prevnar regulatory update

...Japan's Ministry of Health, Labor and Welfare (MHLW) recommended resuming use of pediatric vaccines ActHIB from...
...after reports surfaced of 5 deaths in patients receiving the products (see BioCentury, March 14). ActHIB...
BioCentury | Apr 4, 2011
Clinical News

ActHIB regulatory update

...Japan's Ministry of Health, Labor and Welfare (MHLW) recommended resuming use of pediatric vaccines ActHIB from...
...after reports surfaced of 5 deaths in patients receiving the products (see BioCentury, March 14). ActHIB...
...gained Prevenar through its acquisition of Wyeth . sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Product: ActHIB...
BioCentury | Mar 21, 2011
Company News

Daiichi Sankyo, sanofi-aventis sales and marketing update

...sanofi-aventis' Sanofi Pasteur S.A. vaccines unit will voluntarily recall 13 lots of its ActHIB Haemophilus influenza...
...Ministry of Health, Labor and Welfare (MHLW) decision earlier this month to suspend use of ActHIB...
...by an MHLW safety committee that there was no direct link between the deaths and ActHIB...
BioCentury | Mar 14, 2011
Clinical News

ActHIB regulatory update

...Japan's Ministry of Health, Labor and Welfare (MHLW) suspended use of pediatric vaccines ActHIB from sanofi-aventis...
...deaths and immunization with the vaccines. sanofi said MHLW is continuing to investigate the issue. ActHIB...
...gained Prevenar through its acquisition of Wyeth . sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Product: ActHIB...
BioCentury | Mar 14, 2011
Clinical News

Prevnar regulatory update

...Japan's Ministry of Health, Labor and Welfare (MHLW) suspended use of pediatric vaccines ActHIB from sanofi-aventis...
...deaths and immunization with the vaccines. sanofi said MHLW is continuing to investigate the issue. ActHIB...
BioCentury | Jul 6, 2009
Clinical News

ActHIB regulatory update

...from Merck & Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.). sanofi pasteur's marketed Hib-containing vaccines are ActHIB...
...supplies of Comvax would be made available again. sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Product: ActHIB...
BioCentury | Jul 6, 2009
Clinical News

Pentacel regulatory update

...from Merck & Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.). sanofi pasteur's marketed Hib-containing vaccines are ActHIB...
Items per page:
1 - 10 of 13